Figure 3.

Proportion of patients receiving repeat prostate biopsy, PSA tests, and prostate MRI during observation for low- and intermediate-risk prostate cancer.

Proportion of patients receiving repeat prostate biopsy, PSA tests, and prostate MRI during observation for low- and intermediate-risk prostate cancer.